HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators.

Abstract
Parenteral nutrition (PN)-associated liver disease (PNALD) is a life-threatening complication of the administration of PN. The development of PNALD may be partly due to the composition of the lipid emulsion administered with PN: soybean oil-based lipid emulsions (SOLE) are associated with liver disease, while fish oil-based lipid emulsions (FOLE) are associated with prevention and improvement of liver disease. The objective of this study was to determine how the choice of lipid emulsion modified the production of bioactive lipid mediators (LMs). We utilized a mouse model of steatosis to study the differential effect of FOLE and SOLE. We subsequently validated these results in serum samples from a small cohort of human infants transitioning from SOLE to FOLE. In mice, FOLE was associated with production of anti-inflammatory, proresolving LMs; SOLE was associated with increased production of inflammatory LMs. In human infants, the transition from SOLE to FOLE was associated with a shift toward a proresolving lipidome. Together, these results demonstrate that the composition of the lipid emulsion directly modifies inflammatory homeostasis.
AuthorsBrian T Kalish, Hau D Le, Jonathan M Fitzgerald, Samantha Wang, Kyle Seamon, Kathleen M Gura, Karsten Gronert, Mark Puder
JournalAmerican journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 305 Issue 11 Pg. G818-28 (Dec 2013) ISSN: 1522-1547 [Electronic] United States
PMID24091595 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Emulsions
  • Fatty Acids, Omega-3
  • Inflammation Mediators
  • Soybean Oil
Topics
  • Administration, Oral
  • Animals
  • Emulsions
  • Fatty Acids, Omega-3 (administration & dosage, metabolism, pharmacology, therapeutic use)
  • Fatty Liver (blood, drug therapy, metabolism)
  • Female
  • Humans
  • Infant
  • Inflammation Mediators (metabolism)
  • Injections, Intravenous
  • Male
  • Mice
  • Soybean Oil (administration & dosage, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: